Today, we’re talking about a fascinating topic that has been generating buzz in both the peptide and medical and wellness communities: microdosing GLP-1 agonists for overall health. In this episode, we’ll explore how this emerging practice could impact metabolic health, weight management, and even longevity. Let’s break down what we know and what it could […]
glp1
Gut Check: Exploring GLP-1 Agonists and Microbiome Health
In today’s episode, we’re diving into an exciting topic: how GLP-1 agonists, like Ozempic and Wegovy, are not only transforming metabolic health but also influencing the gut microbiome. We’ll explore the science behind it and practical ways to optimize your health. What Are GLP-1 Agonists?GLP-1 agonists are medications initially developed to manage diabetes, but they’ve […]
GLP-1 Agonists for Chronic Kidney Disease (CKD)
Imagine a treatment that not only helps manage diabetes but also holds the potential to reverse kidney failure — what was once thought to be impossible. The recent FLOW study has remarkable groundbreaking evidence that GLP-1 receptor agonists can significantly improve kidney function in chronic kidney disease (CKD) patients. And while researchers try to understand […]
How GLP-1 Agonists May Improve NASH
Have you heard of fatty liver disease? Well, fatty liver disease is just what it sounds like—it’s when fat builds up in the liver and starts causing issues. The official name for it is “nonalcoholic fatty liver disease,” or NAFLD for short. Now, if that fat buildup leads to inflammation, it’s called “nonalcoholic steatohepatitis,” or […]
Differences Between Semaglutide and Tirzepatide
Two of the most promising treatments for obesity in recent years are semaglutide, a GLP-1 agonist, and tirzepatide, a dual GLP-1/GIP agonist. These peptides have garnered attention for their impressive efficacy in weight loss and metabolic improvement, but they differ in their mechanisms, dosing, side effects, and outcomes. In this podcast, we’ll explore how these […]
Weight Loss Plateau with GLP-1 Agonists
In the journey of weight loss, everyone eventually reaches a plateau, even when using newer GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound). This phase is where the body finds a new set point and weight. During this plateau, some individuals may experience a gradual increase in appetite or “food noise”, while others can […]